Specialty Drug Spending in 2018 Highlights SPT Week in Review

5. FDA Approves Two Fixed Dose HIV Treatments

New combination therapy gains approval for adult and pediatric patients with HIV-1. Read more.

4. Castration-Sensitive Prostate Cancer Drug Gets FDA Greenlight

FDA expands the indication of abiraterone acetate (Zytiga) to include more patients with prostate cancer. Read more.

3. Top 3 Legislative Priorities for Pharmacists

Direct and indirect remuneration fees remain a top concern for pharmacists in 2018. Read more.

2. Personalized Medicine Approvals Continued to Surge in 2017

Thirty-five percent of drug approvals in 2017 were personalized drugs. Read more.

1. Top 8 Specialty Drug Categories Driving Spending in 2018

Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending. Read more.